id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-4963-0001,FDA,FDA-2019-N-4963,"Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of
Meeting; Establishment of a Public Docket; Request for Comments",Notice,Request for Comments,2019-11-21T05:00:00Z,2019,11,2019-11-21T05:00:00Z,2019-12-14T04:59:59Z,2019-12-15T02:01:07Z,2019-25247,0,0,090000648418fb7f